Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be in Booth 10 at the European Conference on Interventional Oncology (ECIO 2023) in Stockholm, Sweden, on April 16 – 19.  They are looking forward to connecting with clinical experts and learning from their experiences, as well as discussing how Immunophotonics continues to explore the ability of IP-001 to transform a routine interventional-oncology procedure into a systemic immunotherapy against cancer.